A Lifeline for the Rare: How New Funding is Changing Lives in Saskatchewan

Read Healthcare & Pharma General Updates

Date: 10th Jan, 2025 Source: In-House Country: Canada

Brief

On January 10, 2025, Health Canada issued an update regarding "Government of Canada signs bilateral agreement with Saskatchewan to improve access to drugs for rare diseases". A $40 million investment was announced to enhance access to new and existing drugs for rare diseases in Saskatchewan. The funding will support the province in delivering three specific drugs: Poteligeo, Oxlumo, and Epkinly, among others, through a pan-Canadian Pharmaceutical Alliance price negotiation process.

This content is restricted.

Highlights content goes here...

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

A Lifeline for the Rare: How New Funding is Changing Lives in Saskatchewan

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

A Lifeline for the Rare: How New Funding is Changing Lives in Saskatchewan

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.